NCT02081404View on ClinicalTrials.gov

Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

March 1, 2009

Primary Completion Date

January 5, 2020

Study Completion Date

August 5, 2020

Conditions
Non-erosive Reflux Disease
Interventions
DRUG

Esomeprazole

standard dose of proton pump inhibitor by mouth once a day for 30 days

DRUG

Placebo

placebo

Trial Locations (2)

64128

Department of Veterans Affairs Medical Center, Kansas City

NG7 2UH

Queen Medical Center, Nottingham

Sponsors
All Listed Sponsors
collaborator

Kansas City Veteran Affairs Medical Center

FED

lead

Midwest Biomedical Research Foundation

OTHER

NCT02081404 - Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study | Biotech Hunter | Biotech Hunter